Cell replacement therapies hold great therapeutic potential. Nevertheless, our knowledge of the mechanisms governing the developmental processes is limited, impeding the quality of differentiation protocols. Generating insulin-expressing cells in vitro is no exception, with the guided series of differentiation events producing heterogeneous cell populations that display mixed pancreatic islet phenotypes and immaturity. The achievement of terminal differentiation ultimately requires the in vivo transplantation of, usually, encapsulated cells. Here we show the impact of cell confinement on the pancreatic islet signature during the guided differentiation of alginate encapsulated human induced pluripotent stem cells (hiPSCs). Our results show t...
Human multipotent stromal cells (hMSC) can induce islet regeneration after transplantation via the s...
<div><p>Human embryonic stem cells (hESCs) are pluripotent and capable of undergoing multilineage di...
Type 1 diabetes is caused by the autoimmune destruction of insulin-producing β-cells. Even with adva...
Cell replacement therapies hold great therapeutic potential. Nevertheless, our knowledge of the mech...
Human islet transplantation can provide glycaemic control in diabetic recipients without the need fo...
We present here a robust and reliable protocol by which to differentiate pancreatic islet-like aggre...
AbstractThere are several challenges to successful implementation of a cell therapy for insulin depe...
Background: Regarding regenerative medicine for diabetes, accessible sources of Mesenchymal Stem Cel...
We have examined long-term cultured, human islet-derived stem/precursor cells (hIPC). Whole human is...
Summary: In type 1 diabetes, a renewable source of human pancreatic β cells, in particular from huma...
Abstract Background aims Induced pluripotent stem cells (iPSCs) have the capacity to generate β c...
Background: In type I diabetes mellitus (T1DM) pancreatic beta cells are destroyed. Treatment entail...
Background: Embryonic stem cells (ESCs) have been implicated to have tremendous impact in regenerati...
Abstract Human embryonic stem cells (hESC) and induced pluripotent stem cells (hiPSC) are considered...
Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endoc...
Human multipotent stromal cells (hMSC) can induce islet regeneration after transplantation via the s...
<div><p>Human embryonic stem cells (hESCs) are pluripotent and capable of undergoing multilineage di...
Type 1 diabetes is caused by the autoimmune destruction of insulin-producing β-cells. Even with adva...
Cell replacement therapies hold great therapeutic potential. Nevertheless, our knowledge of the mech...
Human islet transplantation can provide glycaemic control in diabetic recipients without the need fo...
We present here a robust and reliable protocol by which to differentiate pancreatic islet-like aggre...
AbstractThere are several challenges to successful implementation of a cell therapy for insulin depe...
Background: Regarding regenerative medicine for diabetes, accessible sources of Mesenchymal Stem Cel...
We have examined long-term cultured, human islet-derived stem/precursor cells (hIPC). Whole human is...
Summary: In type 1 diabetes, a renewable source of human pancreatic β cells, in particular from huma...
Abstract Background aims Induced pluripotent stem cells (iPSCs) have the capacity to generate β c...
Background: In type I diabetes mellitus (T1DM) pancreatic beta cells are destroyed. Treatment entail...
Background: Embryonic stem cells (ESCs) have been implicated to have tremendous impact in regenerati...
Abstract Human embryonic stem cells (hESC) and induced pluripotent stem cells (hiPSC) are considered...
Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endoc...
Human multipotent stromal cells (hMSC) can induce islet regeneration after transplantation via the s...
<div><p>Human embryonic stem cells (hESCs) are pluripotent and capable of undergoing multilineage di...
Type 1 diabetes is caused by the autoimmune destruction of insulin-producing β-cells. Even with adva...